Remedy for pemphigoid
US7449177B2 · kind B2 · utility
Assignees
Inventor
Key dates
| Filing date | Dec 26, 2003 |
| Grant date | Nov 11, 2008 |
| Priority date | — |
| Expiry date | Dec 26, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An agent for treatment of pemphigoid is provided.For use as an agent for treatment of pemphigoid, IFN-γ is administered in a dose of 2,000,000 JRU once daily for 7 days by intravenous drip infusion. Depending on symptoms, side effects and age of a patient, the dose can be change, or the dosage can changed to intravenous drip infusion given once in several days. IFN-γ is fast-acting against pemphigoid, involves few side effects, and is considered to be effective. The mechanism of action is presumed to be that IFN-γ suppresses the chemotaxis and function of eosinophils which are considered to be directly involved in the occurrence of pemphigoid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.